← SynDRA
LINAPRAZAN
SynDRA canonical compound SYN0016592 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ATP12A |
|---|
| Mechanism of action | ATP-sensitive potassium channel inhibitor |
|---|
All known targets
- ATP12A
- ATP4A
- ATP4A; ATP4B
Mechanisms of action (all sources)
- ATP4A INHIBITOR
- ATP-sensitive potassium channel inhibitor
- Modulator
Cross-references
Synonyms
- AZD-0865
- AR-H044277
- AZD 0865
- E0OU4SC8DP
- LINAPRAZANUM
- RefChem:153489
- DTXCID60818042
- AZD0865
- Linaprazan [INN]
- Linaprazan [INN:BAN]
- UNII-E0OU4SC8DP
- AZD0865(Linaprazan)
- AZD0865(Linaprazan)?
- orb1309953
- SCHEMBL1138353
- GTPL13761
- GHVIMBCFLRTFHI-UHFFFAOYSA-N
- GLXC-26946
- BDBM50268741
- MFCD30343852
- AKOS030526751
- compound 2 [PMID: 19467868]
- CS-5725
- MS-25870
- DB-302288
- HY-100412
- F85407
- T10435
- F979317
- لينابرازان
- Linaprazan mesylate
- SCHEMBL1138430
- orb1696461
- T32760
- UNII-5P098C89CG
- Linaprazan mesilate
- AZD-0865 mesylate
- linaprazan mesylate
Look up LINAPRAZAN in the interactive SynDRA portal →